Shares of PB Fintech Ltd, parent company of online insurance platform Policybazaar, saw a 4% surge on Friday, hitting a high of Rs 1,262 apiece. This uptick followed an analyst meet where the company's management discussed its future strategy.
Despite the immediate positive market reaction, several prominent brokerages subsequently revised their target prices downwards. The primary concern stems from proposed changes by the Insurance Regulatory and Development Authority of India (IRDAI), which could significantly impact the company's core online insurance revenue.
Regulatory Proposals Prompt Brokerage Adjustments
The IRDAI's proposals, if implemented as suggested, could lead to a potential 30% hit to PB Fintech's FY28 core online insurance revenue. This outlook has prompted a re-evaluation of the stock by financial analysts.
Foreign brokerage Nomura India noted that PB Fintech's management indicated a shift from a "growth at any cost" mindset to a "rationalized growth" approach. This strategic pivot includes plans to trim marketing expenses and slow down hiring, though no mass layoffs are anticipated.
Brokerage Ratings and Revised Targets:
- Haitong International cut its target price to Rs 1,560 from Rs 2,080.
- Jefferies maintained a 'Buy' rating but lowered its target to Rs 1,540 from Rs 2,050.
- BofA Securities suggested a 'Neutral' rating with a target of Rs 1,410. They believe the impact on Policybazaar’s life and term business is manageable, with room for market share gains.
- HSBC downgraded the stock to 'Hold' and set a new target of Rs 1,150, down from Rs 2,100.
- MOFSL (Motilal Oswal Financial Services) reiterated a 'Neutral' rating with a revised target of Rs 1,150. MOFSL warned that if IRDAI's proposals lead to a 30% revenue cut without expense adjustments, earnings could decline by 46%.
Analysts largely agree that until the final IRDAI regulations are officially announced, the stock may continue to experience volatility and potential underperformance.